Secnidazole
Secnidazole (RP-14539) is an orally active azole antibiotic and a imidazole mitigator of Serratia marcescens virulence. Secnidazole, as an analog of acylhomoserine lactones, effectively inhibits QS resulting in the attenuation of Pseudomonas aeruginosa pathogenesis. Secnidazole has antimicrobial activity against many anaerobic Gram-negative and Gram-positive bacterial species in vitro. Secnidazole can be used for the research of various diseases, such as amoebiasis and giardiasis, and bacterial vaginitis[1][2][3].
Product Specifications
CAS Number
3366-95-8
Product Name Alternative
RP-14539; PM-185184
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Bacterial; Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Secnidazole.html
Purity
99.99
Solubility
DMSO : ≥ 30 mg/mL|H2O : 25 mg/mL (ultrasonic)
Smiles
OC(C)CN1C([N+]([O-])=O)=CN=C1C
Molecular Formula
C7H11N3O3
Molecular Weight
185.18
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Amebae
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Takifugu rubripes Homeobox protein Hox-D9a (hoxd9a)
Recombinant Takifugu rubripes Homeobox protein Hox-D9a (hoxd9a)
Recombinant Takifugu rubripes Homeobox protein Hox-D9a (hoxd9a)
Recombinant Takifugu rubripes Homeobox protein Hox-D9a (hoxd9a)
Recombinant Takifugu rubripes Homeobox protein Hox-D9a (hoxd9a)